CRBP — Corbus Pharmaceuticals Holdings Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-PBF Energy, Crown Castle, Definium Therapeutics
U.S. STOCKS ON THE MOVE-AI stocks, energy companies, Johnson & Johnson
U.S. STOCKS ON THE MOVE-US energy stocks, Baldwin, Johnson & Johnson
Corbus gains on weight-loss data for obesity drug in early-stage study
Corbus Pharmaceuticals Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.26 a share - Earnings Preview
Brief: Corbus Pharmaceuticals Announces FDA Clearance To Initiate Tempo-1 Registrational Study Of Crb-701 In Patients With 2L Oropharyngeal Cancer
Brief: Corbus Pharmaceuticals Reports Updated Crb-701 Phase 1/2 Clinical Data Demonstrating Robust Activity In 2L Oropharyngeal And Cervical Cancers
U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy
Brief: Corbus Pharmaceuticals Announces The Appointment Of Nishant Saxena As Chief Business Officer
Brief: Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger To Board Of Directors
U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings
Brief: Corbus Pharmaceuticals Announces Broad Alignment With FDA On Registration Path For Crb-701 In Second-Line Hnscc And Cervical Cancer
Corbus Pharmaceuticals Q4 net loss widens on higher clinical development costs
Brief: Corbus Pharmaceuticals Reports Results From Phase 1A Study Of Oral CB1 Inverse Agonist CRB-913 For The Treatment For Obesity Demonstrating Favorable Safety Profile And Emerging Evidence Of Weight Loss
Corbus Pharma Q3 net loss widens to $23.3 mln
U.S. STOCKS ON THE MOVE-Dominion Energy, Reddit, Brighthouse Financial
U.S. STOCKS ON THE MOVE-Dominion Energy, Reddit, Western Digital
U.S. STOCKS ON THE MOVE-Apple, First Solar, Reddit